265 related articles for article (PubMed ID: 18799464)
41. Effects of cystic fibrosis airway secretions on rat lung: role of neutrophil elastase.
Rees DD; Brain JD
Am J Physiol; 1995 Aug; 269(2 Pt 1):L195-202. PubMed ID: 7653580
[TBL] [Abstract][Full Text] [Related]
42. Human pre-elafin inhibits a Pseudomonas aeruginosa-secreted peptidase and prevents its proliferation in complex media.
Bellemare A; Vernoux N; Morisset D; Bourbonnais Y
Antimicrob Agents Chemother; 2008 Feb; 52(2):483-90. PubMed ID: 18025118
[TBL] [Abstract][Full Text] [Related]
43. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T
Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411
[TBL] [Abstract][Full Text] [Related]
44. DNase I acutely increases cystic fibrosis sputum elastase activity and its potential to induce lung hemorrhage in mice.
Cantin AM
Am J Respir Crit Care Med; 1998 Feb; 157(2):464-9. PubMed ID: 9476859
[TBL] [Abstract][Full Text] [Related]
45. Inflammatory lung secretions inhibit dendritic cell maturation and function via neutrophil elastase.
Roghanian A; Drost EM; MacNee W; Howie SE; Sallenave JM
Am J Respir Crit Care Med; 2006 Dec; 174(11):1189-98. PubMed ID: 16959917
[TBL] [Abstract][Full Text] [Related]
46. Thioredoxin and dihydrolipoic acid inhibit elastase activity in cystic fibrosis sputum.
Lee RL; Rancourt RC; del Val G; Pack K; Pardee C; Accurso FJ; White CW
Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L875-82. PubMed ID: 16214824
[TBL] [Abstract][Full Text] [Related]
47. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
48. Expression of MIG/CXCL9 in cystic fibrosis and modulation of its activities by elastase of Pseudomonas aeruginosa.
Jovic S; Shikhagaie M; Mörgelin M; Kjellström S; Erjefalt J; Olin AI; Frick IM; Egesten A
J Innate Immun; 2014; 6(6):846-59. PubMed ID: 25115612
[TBL] [Abstract][Full Text] [Related]
49. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa.
Jones AM; Martin L; Bright-Thomas RJ; Dodd ME; McDowell A; Moffitt KL; Elborn JS; Webb AK
Eur Respir J; 2003 Sep; 22(3):503-6. PubMed ID: 14516142
[TBL] [Abstract][Full Text] [Related]
50. Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors.
Schuster A; Fahy JV; Ueki I; Nadel JA
Eur Respir J; 1995 Jan; 8(1):10-4. PubMed ID: 7744174
[TBL] [Abstract][Full Text] [Related]
51. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis.
Elborn JS; Cordon SM; Shale DJ
Pediatr Pulmonol; 1993 May; 15(5):287-91. PubMed ID: 8327287
[TBL] [Abstract][Full Text] [Related]
52. KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa.
Jain R; Beckett VV; Konstan MW; Accurso FJ; Burns JL; Mayer-Hamblett N; Milla C; VanDevanter DR; Chmiel JF;
J Cyst Fibros; 2018 Jul; 17(4):484-491. PubMed ID: 29292092
[TBL] [Abstract][Full Text] [Related]
53. Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection.
Staudinger BJ; Muller JF; Halldórsson S; Boles B; Angermeyer A; Nguyen D; Rosen H; Baldursson O; Gottfreðsson M; Guðmundsson GH; Singh PK
Am J Respir Crit Care Med; 2014 Apr; 189(7):812-24. PubMed ID: 24467627
[TBL] [Abstract][Full Text] [Related]
54. The role of bacterial proteases in the pathogenesis of cystic fibrosis.
Suter S
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S118-22. PubMed ID: 7952646
[TBL] [Abstract][Full Text] [Related]
55. Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis.
Naudin C; Joulin-Giet A; Couetdic G; Plésiat P; Szymanska A; Gorna E; Gauthier F; Kasprzykowski F; Lecaille F; Lalmanach G
PLoS One; 2011; 6(9):e25577. PubMed ID: 21980493
[TBL] [Abstract][Full Text] [Related]
56. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
[TBL] [Abstract][Full Text] [Related]
57. Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection.
Milla CE; Chmiel JF; Accurso FJ; VanDevanter DR; Konstan MW; Yarranton G; Geller DE;
Pediatr Pulmonol; 2014 Jul; 49(7):650-8. PubMed ID: 24019259
[TBL] [Abstract][Full Text] [Related]
58. Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.
Costello CM; O'Connor CM; Finlay GA; Shiels P; FitzGerald MX; Hayes JP
Thorax; 1996 Jun; 51(6):619-23. PubMed ID: 8693445
[TBL] [Abstract][Full Text] [Related]
59. Oxidized elafin and trappin poorly inhibit the elastolytic activity of neutrophil elastase and proteinase 3.
Nobar SM; Zani ML; Boudier C; Moreau T; Bieth JG
FEBS J; 2005 Nov; 272(22):5883-93. PubMed ID: 16279952
[TBL] [Abstract][Full Text] [Related]
60. Poly-L-Lysine compacts DNA, kills bacteria, and improves protease inhibition in cystic fibrosis sputum.
Dubois AV; Midoux P; Gras D; Si-Tahar M; Bréa D; Attucci S; Khelloufi MK; Ramphal R; Diot P; Gauthier F; Hervé V
Am J Respir Crit Care Med; 2013 Sep; 188(6):703-9. PubMed ID: 23947381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
